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ABSTRACT Varicella-zoster virus (VZV), a double-stranded DNA virus, causes vari-
cella, establishes lifelong latency in ganglionic neurons, and reactivates later in life
to cause herpes zoster, commonly associated with chronic pain. The VZV genome is
densely packed and produces multitudes of overlapping transcripts deriving from
both strands. While 71 distinct open reading frames (ORFs) have thus far been ex-
perimentally defined, the full coding potential of VZV remains unknown. Here, we
integrated multiple short-read RNA sequencing approaches with long-read direct
RNA sequencing on RNA isolated from VZV-infected cells to provide a compre-
hensive reannotation of the lytic VZV transcriptome architecture. Through pre-
cise mapping of transcription start sites, splice junctions, and polyadenylation
sites, we identified 136 distinct polyadenylated VZV RNAs that encode canonical
ORFs, noncanonical ORFs, and ORF fusions, as well as putative noncoding RNAs
(ncRNAs). Furthermore, we determined the kinetic class of all VZV transcripts and
observed, unexpectedly, that transcripts encoding the ORF62 protein, previously des-
ignated Immediate-Early, were expressed with Late kinetics. Our work showcases the
complexity of the VZV transcriptome and provides a comprehensive resource that
will facilitate future functional studies of coding RNAs, ncRNAs, and the biological
mechanisms underlying the regulation of viral transcription and translation during
lytic VZV infection.
IMPORTANCE Transcription from herpesviral genomes, executed by the host RNA
polymerase II and regulated by viral proteins, results in coordinated viral gene ex-
pression to efficiently produce infectious progeny. However, the complete coding
potential and regulation of viral gene expression remain ill-defined for the human
alphaherpesvirus varicella-zoster virus (VZV), causative agent of both varicella and
herpes zoster. Here, we present a comprehensive overview of the VZV transcriptome
and the kinetic class of all identified viral transcripts, using two virus strains and two
biologically relevant cell types. Additionally, our data provide an overview of how
VZV diversifies its transcription from one of the smallest herpesviral genomes. Unex-
pectedly, the transcript encoding the major viral transactivator protein (pORF62) was
expressed with Late kinetics, whereas orthologous transcripts in other alphaherpesvi-
ruses are typically expressed during the immediate early phase. Therefore, our work
both establishes the architecture of the VZV transcriptome and provides insight into
regulation of alphaherpesvirus gene expression.
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Varicella-zoster virus (VZV) is a ubiquitous human alphaherpesvirus and causativeagent of both varicella (chickenpox) and herpes zoster (HZ or shingles) (1). Varicella
results from primary VZV infection and leads to the establishment of a lifelong latent
infection in sensory neurons of the trigeminal and dorsal root ganglia (2, 3). In one-third
of infected individuals, VZV reactivates from latency later in life to cause HZ (1).
Whereas varicella is generally experienced as a benign childhood disease, HZ is
frequently associated with difficult-to-treat chronic pain (postherpetic neuralgia) (4, 5).
Despite the recent availability of the highly effective HZ subunit vaccine (Shingrix), the
health and societal burden of HZ and its complications remain high due to adverse side
effects, the high cost of the vaccines, and changing demographics (6).
The 125-kb double-stranded DNA (dsDNA) genome of VZV, first sequenced in 1986,
encodes at least 71 unique open reading frames (ORFs) that are expressed during lytic
infection (7, 8). The current annotation of the VZV genome largely relies on both in silico
ORF predictions and homologous ORFs in the closely related human alphaherpesvirus
herpes simplex virus 1 (HSV-1) (8). For most VZV ORFs, the boundaries of transcription
are not accurately determined, meaning that transcription start sites and polyadenyl-
ation sites are poorly resolved. Moreover, in silico ORF prediction does not account for
the possibility of spliced transcripts. Indeed, we recently applied ultradeep short-read
RNA sequencing to define the latent viral transcriptome and discovered the spliced VZV
latency-associated transcript (VLT) (9).
The compact nature of viral genomes, combined with their ability to encode
overlapping RNAs, presents a significant challenge to studies that rely on interrogating
genome sequences or that use viral mutants to probe the function(s) of viral proteins.
Here, a single point mutation or frameshift may impact multiple distinct RNAs at the
same time, a factor that may be further confounded by inaccurate or missing transcript
annotations. The reannotation of the human cytomegalovirus (HCMV) transcriptional
and translational landscape and subsequent refinements of HSV-1, Kaposi’s sarcoma-
associated herpesvirus (KSHV), and human herpesvirus 6 (HHV6) transcriptome archi-
tectures have all demonstrated that herpesviruses exhibit a complex transcriptional
pattern of alternative splicing, opposing transcription, read-through transcription, fu-
sion transcripts, 5= untranslated region (5= UTR) and 3= UTR variations, and previously
unidentified noncoding RNAs (ncRNAs) (10–17). Indeed, recent cDNA-based long-read
sequencing also indicated that the lytic VZV transcriptome is substantially more com-
plex than previously recognized (18).
By analogy to other herpesviruses and limited experimental data (19, 20), VZV
transcripts and their encoded proteins have been divided into three kinetic classes:
immediate early (IE), early (E), and late (L). Expression of E and L transcripts is considered
dependent on viral proteins of the preceding kinetic classes, while expression of IE
transcripts occurs in the absence of viral protein synthesis (21). Prior studies have
defined four VZV proteins encoded by ORF4, ORF61, ORF62, and ORF63 as being
transcriptional regulators that initiate lytic transcript expression (22–26), whose corre-
sponding transcripts have been classified as IE by analogy to their HSV-1 orthologues.
L transcripts, such as lytVLT, the lytic isoform of VLT, are expressed either at very low
levels prior to or exclusively after viral DNA replication has commenced (9). However,
the species specificity and highly cell-associated nature of VZV in vitro have hampered
detailed analysis of VZV transcription. Improved protocols to obtain cell-free VZV and
mass spectrometry have provided some insight into the temporal pattern of viral
protein expression (27) but lack sensitivity compared to RNA sequencing and do not
provide information on viral transcription.
To address this, we have decoded the architecture of the lytic VZV transcriptome in
both human epithelial cells and neurons while contrasting discrete VZV strains. We
subsequently established the kinetic class of all lytic viral transcripts and integrated
these results to provide a comprehensive overview of the complexity and structure of
the lytic VZV transcriptome as a rich resource that will enhance future functional studies
of VZV biology.
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RESULTS
Decoding the complexity of lytic VZV gene expression. Standard methods for
annotating viral transcriptomes require the integration of multiple types of Illumina
RNA sequencing (RNA-Seq) data to identify transcription start sites (TSS), cleavage and
polyadenylation sites (CPAS), splice sites, and transcript structures. The last is particu-
larly challenging to infer using conventional short-read sequencing approaches (28). In
contrast, direct RNA sequencing (dRNA-Seq) using Nanopore arrays offers the potential
to capture all these distinct data points in a single sequencing run (10, 29). To examine
the structure of the lytic VZV transcriptome, ARPE-19 cells were infected with the VZV
pOka wild-type strain and total RNA was extracted at 96 h post-infection (hpi) (Fig. 1A).
The 96-hpi time point was chosen to maximize the diversity of VZV transcripts likely to be
present. Sequencing of the polyadenylated RNA fraction was performed using both RNA-
Seq and dRNA-Seq (Fig. 1A). Whereas short reads generated by standard Illumina RNA-Seq
are not amenable for accurate isoform reconstruction in complex reads, they provide
higher sequencing depth and detection of CPAS and, crucially, enable splice-site correction
of dRNA-Seq reads via the junction-polishing package in the software FLAIR (30). In
contrast, dRNA-Seq can sequence full-length RNAs and provides critical information on the
presence of discrete RNA isoforms with regions of overlap, while also allow mapping of TSS
and CPAS. Finally, we performed Illumina Cap Analysis Gene Expression Sequencing
(CAGE-Seq) (31) to map TSS by an orthologous approach (Fig. 1A).
TSS and CPAS estimates provided by dRNA-Seq data closely overlapped those
derived from our Illumina approaches (Fig. 1B). TSS sensitivity was nearly 4-fold higher
FIG 1 Decoding the complexity of the lytic VZV transcriptome. (A) Experimental strategy: ARPE-19 cells and hESC-derived neurons were infected with VZV
EMC-1 (clade 1) or pOka (clade 2) for 96 h. Total RNA was extracted, and poly(A) fraction was isolated for sequencing by Illumina CAGE-Seq, Illumina RNA-Seq,
and/or Nanopore dRNA-Seq. Sequence data were aligned against the VZV strain Dumas reference genome (GenBank accession no. NC_001348.1) and visualized
using the Integrative Genomics Viewer (IGV) (32) and GVIZ (74). (B) Transcription start sites (TSS) as well as cleavage and polyadenylation sites (CPAS) were
identified in Nanopore and Illumina data sets. Histograms show the distances observed between Nanopore and Illumina predictions, while inset Venn diagrams
indicate the numbers of sites identified and their conservation between data sets. (C) Integration of Illumina RNA-Seq, Illumina CAGE-Seq, and Nanopore
dRNA-Seq data sets. Coverage plots for Illumina RNA-Seq (light blue), CAGE-Seq (red), and Nanopore dRNA-Seq (teal) are integrated with pileup data that maps
TSS (red) and CPAS (black). Rows denoted by TSS and CPAS indicate positions of TSS and CPAS identified using HOMER software (77) for Nanopore dRNA-Seq
and Illumina CAGE-Seq data, and ContextMap2 software (71) for Illumina RNA-Seq data. TSS and CPAS that are conserved between sequencing technologies
are indicated with asterisks, and only these are used to define the boundaries of newly annotated transcripts. RNA structures (gray) are inferred from these
conserved sites. Wide and thin boxes indicate canonical coding sequence (CDS) domains and untranslated regions (UTRs), respectively. Newly identified RNAs
(orange) are shown without predicted CDS domains.
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in CAGE-Seq data sets than with dRNA-Seq, with effectively all TSS uniquely found by
CAGE-Seq being low abundance—likely reflecting artifacts derived from RNA process-
ing (i.e., recapping of cleaved RNA) or a generalized dysregulation of transcription
initiation accompanying the late stages of a viral infection. A total of 104 TSS over-
lapped between the dRNA-Seq and CAGE-Seq data sets, all of which were the most
abundant TSS in both data sets (see Table S1 in the supplemental material). Impor-
tantly, dRNA-Seq TSS estimates were located up to 20 nucleotides (nt) downstream
(median 11 nt) of TSS derived via CAGE-Seq (Fig. 1B). This difference is best explained
by the presence of low-quality ends of dRNA-Seq reads that are not aligned when using
local alignment strategies. CPAS sensitivity was higher in dRNA-Seq than RNA-Seq data
sets (70 versus 60 sites) with 53 sites detected by both approaches (Table S1). CPAS
estimates provided by dRNA-Seq aligned closely with those derived from RNA-Seq data
(median 1-nt difference, Fig. 1B) due to the 3=¡5= direction of dRNA-Seq. Finally, we
reconstructed the VZV transcriptome using TSS and CPAS to define transcript structures
followed by visual confirmation of read data to identify splice sites, define alternatively
spliced transcripts, and examine read-through transcription (Fig. 1C). For a given
transcript to be included in our final annotation, we required the specified TSS and
CPAS to be present in both CAGE-Seq and dRNA-Seq data sets (Table S1). We further
required that the transcript could be verified by eye through inspection of sequence
read alignments in BED files (available at https://github.com/DepledgeLab/vzv-2.0)
using IGV (32) and that splice junctions (Table S2) were reported in both the RNA-Seq
and dRNA-Seq data sets. This is exemplified in Fig. 1C where five TSS (indicated by
asterisks) were identified by both dRNA-Seq and CAGE-Seq while only a single CPAS
was identified in the RNA-Seq and dRNA-Seq data. This leads us to initially annotating
five distinct transcripts (each with a unique TSS and common CPAS), while further
inspection of the sequence read alignments in IGV confirmed the presence of both an
unspliced and spliced transcript sharing the same TSS and CPAS (shown in orange in
Fig. 1C), resulting in six distinct transcripts in total.
Reannotation of the VZV transcriptome reveals alternative transcript isoforms
and putative noncoding RNAs. In VZV pOka-infected ARPE-19 cells, we identified 136
distinct VZV RNAs that were readily detectable at 96 hpi. Along with defining the UTRs
of 96 RNAs encoding the 71 canonical VZV ORFs, we also identified 40 additional RNAs
(Fig. 2 and Table S3). To reduce confusion, we numbered all RNAs according to the
respective canonical ORFs and delineated transcript isoforms encoding at least part of the
same ORF by number. For instance, three transcripts are transcribed from the ORF0 locus
and these are here referred to as VZV RNA 0-1, 0-2, and 0-3. The identified RNAs included
transcripts encoding 5= extended ORFs, 5= truncated ORFs, 3= extended ORFs, 3= truncated
ORFs, internally spliced variants, and putative noncoding RNAs (ncRNAs). Importantly, our
study confirmed several previously described RNA isoforms such as a genome-terminus-
spanning RNA that encodes ORF0 (RNA 0-3) (33) and identified an additional 5= truncated
ORF0 RNA of unknown function (RNA 0-2) (Fig. 3A). Similarly, extensive low-level internal
splicing of ORF50 has previously been reported (34) (RNAs 50-1 to 50-5) and was similarly
observed here, supplemented by two additional 5= truncated isoforms (RNAs 50-6 and 50-7)
expressed at relatively high abundance (Fig. 3B). Examples of previously undocumented
RNAs include two new spliced ORF9 transcript isoforms and two internally spliced transcript
isoforms containing N-terminal ORF24 and ORF48 coding sequence (CDS) domains that are
spliced into novel C-terminal domains (Fig. 2). Finally, we confirmed expression of tran-
scripts encoding the novel ORF9 and ORF48 variants in VZV-infected ARPE-19 cells by
RT-PCR (Fig. S1A and G and Fig. S1B and H).
Fusion transcripts combine sequences from two or more distinct canonical viral
transcripts and most likely result from transcription termination occurring at an alter-
native CPAS downstream of the canonical CPAS, followed by internal splicing (10). The
resulting fusion transcripts are predicted to encode new proteins that contain fused
domains from two or more distinct protein products. We identified seven VZV fusion
transcripts in total. Four of these contain distinct fusions of transcripts encoding pVLT
and pORF63 (Figure 2, Table S3). Internal splicing of RNA 12-2 and RNA 12-3 transcripts
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FIG 2 Reannotation of the lytic VZV transcriptome reveals novel viral transcript isoforms, fusion transcripts, and putative noncoding RNAs. The reannotated
lytic VZV transcriptome includes 71 transcripts encoding canonical ORFs with their UTRs defined (gray), 39 alternative isoforms of existing RNAs (orange), 7
fusion RNAs (dark blue), and 17 putative polyadenylated ncRNAs (red), the last predicted using CPC 2.0 (36). Wide and thin boxes indicate canonical CDS
domains and UTRs, respectively. Absence of CDS regions indicates that the respective VZV RNA has an uncertain coding potential. Illumina RNA-Seq (light blue)
(Continued on next page)
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yields two distinct splice variants that fuse parts of ORF12 and ORF13 CDS domains
(Fig. 3C). Additionally, we observed transcripts that fused the 5= UTR of ORF31 tran-
scripts to ORF32 transcripts, resulting in a transcript encoding pORF32 with an alter-
native 5= UTR (Fig. 3D). We confirmed expression of transcripts containing the ORF12-
ORF13 and ORF31-ORF32 fusions in VZV-infected ARPE-19 cells by RT-PCR (Fig. S1C and
I and Fig. S1D and J).
Additionally, we discovered two novel polyadenylated VZV transcripts: RNA 13.5-1
and RNA 43-2. RNA 13.5-1 is 634 nt long, encodes two putative CDS domains (88 and
55 amino acids [aa]), and is positioned antisense to the RNA 14-1 (encoding pORF14).
Like RNA 14-1, RNA 13.5-1 stretches across the R2 reiterative region, a short-repeat
region that exhibits length variations between viral strains and within viral populations
and thus leads to length variations in the encoded transcripts (35) (Fig. 2 and Fig. S1E).
We also identified a highly expressed 3= truncated RNA (RNA 43-2) that overlaps the 5=
end of RNA 43-1 (encoding pORF43) (Fig. 2 and Fig. S1F). RNA 43-2 is a spliced 590-nt
transcript that encodes only a short CDS domain (21 aa). Expression of both RNA 13.5-1
and RNA 43-2 in VZV-infected ARPE-19 cells was confirmed by RT-PCR (Fig. S1E and K
and Fig. S1F and L)
Finally, we used an in silico approach to predict the coding potential of all 136
polyadenylated VZV RNAs (Table S3). The Coding Potential Calculator version 2 algo-
rithm (CPC 2.0) (36) calculates the coding probability of a transcript based on its length,
isoelectric point, and Fickett score of the longest CDS encoded. Of the 96 VZV RNAs
FIG 2 Legend (Continued)
and Nanopore dRNA-Seq (teal) coverage plots are derived from ARPE-19 cells lytically infected with VZV strain pOka for 96 h. y axis values indicate the maximum
read depth of that track. See also Fig. S1 and S2. Reiterative repeat regions R1 to R5 and both copies of the OriS are shown as black boxes embedded in the
genome track.
FIG 3 Examples of specific variant and fusion viral RNAs expressed during lytic VZV infection. (A to D) Examples of variant transcripts encoding ORF0 (A) and
ORF50 (B) and novel fusion transcripts encoding (parts of) ORF12 and ORF13 (C) and ORF31 and ORF32 (D). Illumina RNA-Seq (light blue) and Nanopore
dRNA-Seq (teal) coverage plots are derived from ARPE-19 cells lytically infected with VZV strain pOka for 96 h. Fusion RNAs are shown in dark blue, with variant
RNAs shown in orange and canonical RNAs in gray. The dashed red line in panel A indicates the position of the genome termini spanned by RNA 0 to 3. (A
to D) Genome coordinates are shown, while strand is indicated by placement of the genome track (below, top strand; above, bottom strand). y axis values
indicate the maximum read depth of that track. For graphs shown on the right, the y axis denotes transcript per million (TPM) counts.
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encoding the 71 canonical ORFs, 89 were assigned a coding probability exceeding 90%,
with only two canonical RNAs—encoding the two smallest VZV proteins, pORF49 (81 aa)
(37) and pORF57 (71 aa) (38)—incorrectly predicted to be a noncoding transcript (Table S3).
Of the 40 VZV RNAs encoding noncanonical products, 17 were predicted to be noncoding
(Table S3), including two novel transcripts: RNA 13.5-1 (7%) and RNA 43-2 (13%). Notably,
only RNA 43-2 was expressed to relatively high levels as the 37th most abundant transcript
at 24 hpi and 41st most abundant at 96 hpi (out of 136 VZV transcripts).
We next validated a selection of the reported transcript variants through compar-
ative analysis of our sequencing-derived data against Northern blotting approaches
used in prior studies. For instance, prior Northern blot analysis of the VZV RNA 50 locus
(34) identified at least six discrete bands (2,100, 1,800, 1,400, 1,200, 1,000, and 900 nt),
five of which corresponded to six transcripts observed in our data set (1,825, 1,400,
1,362, 1,162, 1,039, and 839 nt). We note that no annotated transcript in our data
matched the observed 2,100-nt band, nor was any band observed that matched our
663-nt transcript variant. Similarly, Northern blotting of the VZV RNA 9 locus (39) demon-
strated the presence of at least three bands, sized approximately 2,400, 1,600, and 1,100 nt
which correspond with RNA 9-1 (1,030 nt), RNA 9A-1 (1,530 nt), and the unspliced precur-
sors for RNA 9-2 and 9-3 (2,373 nt). Note that the presence of mature spliced RNA 9-2
(1,556 nt) and 9-3 (1,814 nt) was confounded by their size relative to RNA 9A-1. Finally, we
performed Northern blotting to confirm the expression of the 698-nt RNA 64-1 and 1,653-nt
polycistronic RNA 63-64, as well as a low-abundance 400-nt RNA 64 variant that was
detected, but not sufficiently evidenced for including in the annotation, in our data sets
(Fig. S1M).
The lytic VZV transcriptome is not influenced by viral strain or cell type. VZV
genome sequences are highly conserved (40), suggesting that strain-specific differ-
ences in coding capacity are likely minimal. To test this hypothesis, we infected ARPE-19
cells with VZV EMC-1 for 96 h and sequenced the poly(A) fraction of RNA by dRNA-Seq
(Table S4). This enabled a comparative analysis of data sets obtained from ARPE-19 cells
lytically infected with either VZV pOka or EMC-1 to determine whether either strain
encodes unique transcripts (Fig. 4). No such transcripts were identified at the RNA level,
although we note that nucleotide level changes may still impact encoded proteins—as
is exemplified by the N-terminal extended pORF0 uniquely present in pOka (Fig. 4C).
As VZV is capable of infecting diverse cell types including epithelial cells and
neurons, we also determined if the VZV transcriptome remains similar between VZV
pOka-infected ARPE-19 cells and human embryonic stem cell (hESC)-derived neurons
(41, 42). Again, no cell-type-specific novel VZV RNAs or variant VZV RNAs were identi-
fied (Fig. 5), indicating that observed differences in VZV RNA expression levels and
infectivity in distinct cell types (41, 43) are not due to the presence of cell-type-specific
VZV RNAs but are likely driven by host cell factors.
Overexpression of RNA 43-2 does not impair VZV replication in epithelial cells.
Based on the high relative expression of RNA 43-2, its low protein coding potential, and
genomic location, we hypothesized that it may function as an ncRNA involved in
regulating the expression of the longer RNA 43-1 (encoding pORF43). RNA 43-1
encodes pORF43 and has previously been designated as an essential gene (44), which
putatively encodes the capsid vertex component 1 and is postulated to be important
for viral DNA encapsidation from the analogy to HSV UL17 (45). To test this hypothesis,
we generated three stable ARPE-19 cell lines expressing RNA 43-2 or an empty vector
as control (Fig. S2A and B) and analyzed VZV EMC-1 replication at 48 and 72 hpi by flow
cytometry and plaque assay. We did not observe any significant differences in number
of VZV-infected cells, number of plaques, or plaque sizes between RNA 43-2-expressing
cells and vehicle control cells (Fig. S2C and D). Additionally, RNA 43-2 expression did
not significantly reduce expression of RNA 43-1 in VZV-infected cells (P  0.08 by
Student’s t test) (Fig. S2E).
Decoding the kinetic class of lytic VZV transcripts. To determine the kinetic class
of each lytic VZV RNA, cell-cycle-synchronized ARPE-19 cells were infected with cell-free
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VZV EMC-1 and cultured for 12 or 24 h in the presence or absence of actinomycin D
(ActD; transcription inhibitor), cycloheximide (CHX; translation inhibitor), or phospho-
noacetic acid (PAA; inhibitor of the viral DNA polymerase), and viral RNAs were
subsequently profiled using dRNA-Seq and RNA-Seq (Fig. 6 and Fig. S3). Transcription
of IE RNAs is not dependent on de novo viral protein production, whereas transcription
of E RNAs depends on IE proteins. L RNAs are further subclassified into two kinetic
classes, Leaky-Late (LL) and True-Late (TL); LL RNAs are expressed at very low levels
before, and TL RNAs exclusively after, viral DNA replication has commenced. To rule out
the possibility of contamination introduced through cell-free infections, we also se-
quenced samples treated with ActD to control for the potential presence of residual
background transcripts in the virus preparations and confirmed only minimal amounts
of VZV transcripts to be present (Fig. S3).
Given the very high sensitivity of our Illumina RNA-Seq and Nanopore dRNA-Seq
analyses, many VZV transcripts were detected under all experimental conditions albeit
at vastly different abundancies (Table S3). To classify VZV transcripts into distinct kinetic
classes in an unbiased fashion, we determined the relative expression of each of the
136 VZV RNAs in CHX-treated, PAA-treated, or untreated samples and clustered tran-
scripts by average correlation (Fig. 7). In total, 8 transcripts were classified as IE and 53
were classified as E RNAs, including the experimentally validated transcripts encoding
pORF28 and pORF29 (46). A further 28 transcripts were classed as LL and 41 transcripts
were classed as TL, the latter including both RNA 14-1 (pORF14) and VLT (pVLT), both
of which have been experimentally confirmed previously (9, 47). Importantly, 4 tran-
scripts were classified as Transactivated/True-Late (TA/TL)—a putative new designation
applied to transcripts that show detectable yet limited expression in CHX-treated
FIG 4 VZV transcriptome diversity is consistent between viral strains. (A) Coverage plots derived from Nanopore dRNA-Seq of VZV strain pOka (blue)- and VZV
strain EMC-1 (red)-infected ARPE-19 cells at 96 hpi. Note that while relative and absolute abundances of distinct VZV RNAs differ between strains, all RNAs
included in our annotation are represented. y axis denotes coverage range. Canonical (gray), alternative (orange), fusion (dark blue), and putative (red) ncRNAs
are shown with canonical CDS regions indicated by wide boxes and UTRs shown as thin boxes. The absence of a CDS region indicates that an RNA has uncertain
coding potential. The reiterative repeat regions R1 to R5 and both copies of the OriS are shown as black boxes embedded in the genome track. (B) The
scatterplot shows the correlation between VZV transcript abundance in VZV EMC-1-infected and VZV pOka-infected ARPE-19 cells. Pearson R2 and P value are
indicated. (C) Identical TSS and CPAS were detected in ARPE-19 cells infected with cell-free VZV pOka (VZV clade 2; yellow) or EMC-1 (VZV clade 1; green) at
96 hpi, yielding two ORF0 RNA isoforms. However, due to nucleotide variability between the two strains, VZV pOka RNA 0-1 includes a larger CDS and can
encode an alternative ORF0 protein variant, compared to VZV EMC-1. Nanopore dRNA-Seq (teal) coverage plots are shown. y axis values indicate the maximum
read depth of that specific track. CDS regions and UTRs are shown as wide and thin boxes, respectively.
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samples, no or minimal expression in PAA-treated samples, and high expression in
untreated samples at 24 hpi. Three VZV transcripts clustered closely with IE RNAs but
showed variable expression patterns. One of these, RNA 0-1 (encoding pORF0), shares
features with both IE and E transcripts and was provisionally classed as IE based on its
relatively high abundance in CHX-treated samples (Table S3), whereas lytVLT63-3
(encoding pORF63) appears to be transactivated during infection and then expressed
with E kinetics (TA/E), and RNA 29-1 showed an expression pattern similar to E
transcripts. Finally, we also note that E transcripts could be classified into two distinct
subgroups termed True-Early and Early-Late, dependent on whether their expression
was reduced or consistent in untreated samples compared to PAA-treated samples.
Collectively, our approach showed that two VZV transcripts (RNA 4-1 and RNA 61-1,
encoding pORF4 and pORF61, respectively) were expressed at very high levels (ac-
counting for 60% of all VZV transcripts in CHX-treated samples [Table S3]) in the
absence of de novo protein production and, in agreement with prior studies (23, 25),
were classified as IE transcripts (Fig. 6 and 7). Six additional transcripts—including both
copies of RNA 63-1 (encoding pORF63)—were expressed to high levels in CHX-treated
samples relative to other conditions and were also assigned IE status, albeit at much
lower levels compared to RNA 4-1 and RNA 61-1. pORF4, pORF61, and pORF63 are
known transcriptional activators of VZV and canonical IE transcripts (22, 23, 25, 48).
ORF62 transcripts are expressed with Late kinetics during lytic VZV infection.
The VZV gene locus 62 is located within a short-repeat region that is duplicated and sits
on either side of the Unique Short (US) region. The gene 62 duplications (62a and 62b)
FIG 5 VZV transcriptome diversity is consistent between infected cell types. (A) Coverage plots derived from Nanopore dRNA-Seq of VZV pOka-infected
ARPE-19 cells (blue) and hESC-derived neurons (purple). RNA was collected at 96 hpi (ARPE-19 cells) or 144 hpi (neurons). Note that while relative and absolute
abundances of distinct VZV RNAs differ between cell types, all RNAs included in our annotation are represented. y axis denotes coverage range. Canonical (gray),
alternative (orange), fusion (dark blue), and putative (red) ncRNAs are shown with canonical CDS regions indicated by wide boxes and UTRs shown as thin boxes.
The absence of a CDS region indicates that the respective VZV RNA has an uncertain coding potential. Reiterative repeat regions R1 to R5 and both copies of
the OriS are shown as black boxes embedded in the genome track. (B) The scatterplot shows the correlation between VZV transcript abundance in hESC-derived
neurons and ARPE-19 cells. Pearson R2 and P value are indicated.
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are considered perfect in that even full-length sequence reads align against both copies
with an equal match. VZV transcripts RNA 62-1 and RNA 62-2 encode, respectively, the
major viral transcriptional activator protein, pORF62, and a predicted N-terminal trun-
cated pORF62 variant. A third transcript (RNA 62-3, TL) shows a 3= truncation that
disrupts the CDS through the absence of a stop codon. While this transcript is predicted
to encode several putative micro-ORFs, it is not known whether any of these are
translated. Surprisingly, our data indicate that following very limited transactivation
during initial infection, expression of these transcripts is dependent on de novo (viral)
protein synthesis and viral DNA replication, thereby classifying these RNA 62 transcripts
as TA/TL. This contradicts the current classification of RNA62-1 (encoding pORF62) as an
IE transcript, although we note that this classification was obtained by analogy to the
function of its HSV-1 orthologue infected cell polypeptide 4 (ICP4) (49). To confirm and
substantiate our findings, we analyzed the impact of viral DNA replication on pORF62-
encoding RNA and protein expression in multiple VZV-susceptible cell types at 24 hpi.
RT-qPCR analysis showed that PAA treatment was associated with an approximately
10-fold decrease in expression of IE transcripts encoding pORF61 and pORF63, consis-
tent with the absence of VZV DNA replication and spread in culture, and a 10,000-fold
decrease in expression of TL, viral DNA replication-dependent, RNA lytVLT (Fig. 8A).
Notably, expression of RNAs encoding pORF62 was more severely affected (500-fold
FIG 6 Decoding the kinetic class of VZV transcripts during lytic infection. Coverage plots derived from dRNA-Seq of ARPE-19 cells infected with cell-free VZV
EMC-1 and treated with cycloheximide (CHX; green) for 12 h or phosphonoacetic acid (PAA; gold) for 24 h or untreated (UNT; red) for 24 h. Corresponding
Illumina RNA-Seq coverage plots for each condition are shown as dark blue line plots. y axis denotes coverage range (left side, Nanopore dRNA-Seq; right side,
Illumina RNA-Seq). Reannotated VZV genome is shown in the middle track. CDS regions and UTRs are shown as wide and thin boxes, respectively. Reiterative
repeat regions R1 to R5 and both copies of the OriS are shown as black boxes embedded in the genome track. Transcripts annotated are colored according
to kinetic class: IE, green; TE, yellow; EL, dark gold; LL, red; TL, dark red; TA/TL, purple; Not classified, gray. Canonical CDS regions are indicated by wide boxes
with UTRs shown as thin boxes. Absence of a CDS region indicates that an RNA has an uncertain coding potential. Reiterative repeat regions R1 to R5 and both
copies of the OriS are shown as black boxes embedded in the genome track.
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reduction) by PAA treatment than that of IE RNAs encoding pORF61 and pORF63.
Similar results were obtained for VZV strain pOka-infected epithelial ARPE-19 cells,
hESC-derived neurons, and lung fibroblast MRC-5 cells (Fig. S4A to C).
Similarly, PAA treatment severely reduced the abundance and affected the cellular
localization of pORF62 in VZV-infected ARPE-19 cells (Fig. 8B). In the absence of PAA,
both pORF61 and pORF62 were abundantly expressed in foci of VZV-infected cells, with
mostly diffuse nuclear pORF61 staining and pORF62 staining presenting as abundant
globular nuclear and diffuse cytoplasmic staining (Fig. 8B, left panels). Consistent with
inhibition of VZV replication, no foci of VZV-infected cells were observed in PAA-treated
cultures and infected cells were rare. The pORF61 staining pattern in infected cells was
comparable between PAA-treated and untreated VZV-infected cells, whereas pORF62
staining intensity was severely reduced and showed weak, mostly diffuse nuclear staining
with fewer intensely staining punctae (Fig. 8B, right panels), possibly reflecting incoming
pORF62 originating from VZV virions. Identical immunofluorescence (IF) staining results
were observed in MRC-5 and melanoma MeWo cells (Fig. S4D and 4E, respectively). Overall,
our data demonstrate that RNA 62-1, as well as RNA 62-2 and RNA 62-3, is expressed at low
levels prior to viral DNA replication, with robust expression occurring only after viral DNA
replication is initiated, consistent with the expression of LL but not IE transcripts.
DISCUSSION
Understanding the full coding capacity of a given virus is crucial to understanding
its biology. With the advent of new RNA-sequencing methodologies, it has become
clear that transcription of herpesvirus genomes is much more complex than previously
anticipated. Here, we demonstrate that VZV is no exception and provide a compre-
hensive reannotation of the VZV transcriptome during lytic infection of human retinal
pigment epithelial cells and hESC-derived neurons, incorporating data from two dis-
tinct VZV strains. By integrating RNA-Seq, CAGE-Seq, and dRNA-Seq, we have resolved
the architecture of the lytic VZV transcriptome. Specifically, we report the TSS and CPAS
for all annotated VZV transcripts—including refinement of the 5= UTRs and 3= UTRs in
RNAs encoding canonical ORFs—and show that VZV further diversifies its transcription
through the use of (i) additional TSS and CPAS, (ii) disruption of transcription termina-
tion, and (iii) alternative splicing. As a result, several transcript isoforms are expressed
FIG 7 Transcriptional classification of VZV transcripts. The kinetic class of each viral transcript annotated here was derived in isolation by comparing its relative
expression in lytically VZV-infected ARPE-19 cells treated with cycloheximide (CHX) or phosphonoacetic acid (PAA) or untreated (UNT). A heatmap was
constructed using ClustVis (76), and transcripts were clustered by correlation. This yielded five discrete groupings. The first showed highest relative expression
in CHX-treated samples and was annotated as viral Immediate-Early (IE) RNAs (n  8). The second group showed high relative expressions levels in PAA-treated
samples and was annotated as viral Early (E) RNAs (n  53). Here, two subclusters were formed based on whether high relative expression was sustained (n  24,
Early-Late [EL]) or transient (n  29, True Late [TE]) in untreated samples. Viral Leaky Late (LL) RNAs (n  28) were those showing some expression in PAA-treated
data sets but higher expression in untreated data sets while viral True Late (TL) RNAs (n  41) were those that showed high expression only in untreated samples.
A final group (n  4) showed detectable yet limited expression in CHX-treated samples, no/minimal expression in PAA-treated samples, and high expression
in untreated samples at 24 hpi and has been putatively classified as Transactivated/True Late (TA/TL).
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from the same locus and fusion RNAs that modify UTRs and CDS of multiple transcripts are
produced. Given that 5= UTR sequences influence the translational efficiency of the down-
stream CDS (50), alternative UTR usage may provide the virus with an additional mecha-
nism to regulate its protein expression throughout its infectious cycle. Collectively, this
study defined 136 polyadenylated VZV RNAs that are expressed during lytic VZV infection,
many of which are predicted to increase the diversity of the viral proteome.
Although the VZV genome is considered relatively stable, multiple strains currently
cocirculate and recombine (40, 51), potentially influencing the viral transcriptome.
However, our comparison of the transcriptional landscape of a VZV clade 1 (strain
EMC-1) and a clade 2 (strain pOka) virus revealed that no strain-specific lytic transcript
isoforms exist in VZV-infected ARPE-19 cells. However, interstrain differences in repeat
variations could nevertheless impact transcription of RNA 11-1 (containing R1), RNA
13.5-1 (R2), RNA 14-1 (R2), RNA 22-1 (R3), RNA 63-2 (R4), RNA 63-3 (R4), and all RNA 59
and RNA 60 isoforms (R5) (35). Similarly, strain-specific polymorphisms may function to
extend coding domains such as the N-terminal extended pORF0 (RNA 0-3) in VZV pOka
in comparison with other VZV clades (Fig. 4C). Additionally, while previous studies
suggested that the VZV transcriptome is generally similar across diverse cell types, none
had sufficient resolution or used the methodologies required to disentangle transcript
structures (9, 43, 52). Here, we demonstrated that identical transcript isoforms were
detected during lytic VZV infection of human retinal pigment epithelial cells and
hESC-derived neurons. Thus, while VZV strain-specific polymorphisms and/or cell type
FIG 8 RNA 62 transcripts are expressed with Late kinetics during lytic VZV infection. Cell cycle-synchronized human ARPE-19 (epithelial), SH-SY5Y
(neuroblastoma), MRC-5 (fibroblast), and MeWo (melanoma) cells were infected with cell-free VZV EMC-1 for 24 h in the presence or absence of PAA. (A) Fold
change in expression of transcripts encoding pORF61, pORF62, and pORF63 in PAA-treated samples relative to untreated samples (calibrator) and normalized
to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using the 2ΔΔCT method. In 1 of 3 experiments, PAA treatment reduced VLT expression to below
detection limit. qPCR primer/probe set directed to the ORF62 CDS recognizes all three transcript variants (RNA 62-1, 62-2, and 62-3). (B) Representative images
of lytically VZV-infected ARPE-19 cells stained by immunofluorescence for pORF61 (green) and pORF62 protein (red). Nuclei were counterstained with Hoechst
33342 (blue). Top row, 400 magnification; bottom rows, 1,000 magnification.
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may influence viral gene expression, their impact on the lytic VZV transcriptome
structure appears to be small.
Many herpesviruses express ncRNAs during lytic and latent infections (53). Previ-
ously, we identified the putative dual-function polyadenylated VZV RNA VLT, which
encodes a protein expressed during lytic infection but is also functional as an RNA,
inhibiting ORF61 RNA expression in overexpression experiments (9). Here, we identified
17 additional polyadenylated VZV RNAs that are predicted to be noncoding. Diverse
functions have been attributed to human ncRNAs, including the modification of
antisense or overlapping transcription events (54, 55). The generation of functional VZV
mutant viruses with impaired expression of identified putative ncRNAs is challenging
due to overlap with other viral transcripts. Therefore, we have studied the function of VZV
RNA 43-2 by means of RNA 43-2 overexpression followed by VZV superinfection. However,
RNA 43-2 did not significantly reduce expression of the overlapping RNA 43-1 transcript nor
influence VZV replication. These results most likely reflect the complexity of VZV transcript
regulation during lytic infection, as putative ncRNA 43-2 is expressed earlier (IE kinetics) and
at higher abundance than RNA 43-1 (E kinetics) (Fig. 6 and 7 and see also Fig. S2F and G
in the supplemental material). Considering the multitude of ncRNAs expressed by other
herpesviruses and their crucial roles during infection (53), delineating the functional im-
portance of VZV ncRNAs should be considered a research goal.
Twenty-eight of 136 VZV transcripts are (multiply) spliced. Strikingly, the majority of
splicing events occur in a hypercomplex region of the VZV genome encoding both
pVLT and pORF61. We have previously shown this locus to be characterized by
extensive alternative splicing (9) and here report the presence of multiple transcripts
that variously encode a fusion protein of pVLT and pORF63 (pVLT-ORF63) or an
N-terminal extended pORF63 (pORF63-N). The coding potential of pVLT-ORF63 or
pORF63-N and functional consequences of (and requirement for) these fusion tran-
scripts during reactivation from latency are described in a separate study (78), while
their functional role(s) during lytic infection is under investigation. Except for lytVLT63-3,
all spliced VZV RNAs used the canonical splice donor (GT) site. The splice donor sites
were highly enriched for C/A (3 position), A (2), G (1), and A (1). All spliced VZV
RNAs used the canonical splice acceptor site (AG), often flanked by C (1) and G/A
(1). Consistent with the use of the cellular splicing machinery to process viral
pre-mRNAs, VZV consensus splice donor and acceptor sites closely resemble those of
the human transcriptome (56).
Herpesvirus transcripts are traditionally assigned kinetic classes based on their
temporal expression pattern and dependence on de novo protein synthesis or viral DNA
replication. Here, we provide an unbiased transcriptome-wide classification of VZV
transcripts during lytic infection of epithelial cells and observed novel patterns of viral
RNA expression, designated TE, EL, and TA/TL, in addition to traditional IE, LL, and TL
kinetic classes. The data suggest that a subset of the relative expression of TE transcripts
is reduced following viral DNA replication, whereas this is not the case for EL transcripts.
Notably, TE VZV RNAs are enriched for transcripts encoding proteins involved in viral
DNA replication (e.g., RNA 16 variants, RNA 28-1, and RNA 51-1 encoding the viral DNA
polymerase processivity factor pORF16, DNA polymerase large subunit pORF28, and
origin-binding protein pORF51, respectively), whereas EL RNAs encode a more diverse
panel of VZV proteins also involved in virion formation and egress (e.g., RNA 31-1 and
37-1 encoding glycoproteins B and H, respectively). TA/TL RNAs were detectable at low
levels in the absence of de novo protein production, but their abundant expression was
highly dependent on viral DNA replication. We hypothesize that transcription of TA/TL
transcripts in CHX-treated samples is due to low-level transactivation by viral tegument
proteins delivered from incoming virions. Additionally, our kinetic classification identi-
fied that multiple transcripts originating from the same locus could either share the
same kinetic class (e.g., RNAs 16-1, 16-2, and 16-3) or be of different kinetic classes (e.g.,
RNAs 9-1, 9-2, 9-3, and 9A-1) (Table S3 and Fig. S3). While the biological impetus for this
is not clear, it seems likely that TSS and CPAS usage are dynamically regulated during lytic
infection. For example, RNA 43-1 (E, pORF43) and the putative ncRNA 43-2 (IE) diverge in
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CPAS usage and expression kinetics (Fig. 7 and Fig. S3). Similarly, multiple transcripts
encoding pORF63 utilizing different TSS are expressed as different temporal classes and
various abundancies, with canonical IE RNA 63-1 being most abundant, followed by E RNA
lytVLT63-3 and low quantities of two TL RNAs, 63-2 and 63-3 (Fig. 7 and Fig. S3).
Finally, our data provide novel insight into the expression of IE transcripts and the
role of pORF62 during lytic VZV infection. The most abundantly expressed VZV IE
transcripts, produced in the absence of new protein synthesis, encode pORF4 and
pORF61, which are also the earliest proteins detected during lytic VZV infection (27).
Interestingly, prior studies of the RNA 4-1 and RNA 61-1 promoter regions have shown
that their efficient transactivation is dependent on pORF62 (57, 58), a major component
of the viral tegument (59). However, our data indicate that abundant expression of VZV
RNA 62-1 (pORF62), as well as RNAs 62-2 and 62-3, is dependent on viral DNA
replication (TL and TA/TL kinetics), suggesting that tegument-derived pORF62 but not
de novo pORF62 transactivates RNA 4-1 and RNA 61-1 expression, at least during
establishment of the lytic infection cycle. Classification of RNA 62-1 (pORF62) as TA/TL
is also supported by prior observations that a marked increase in pORF62 abundance
occurs only after DNA replication has commenced (19). Importantly, our findings do not
exclude any of the previously assigned functions of pORF62, most notably its function
as a major transcriptional regulator of VZV transcripts (60–62). However, future studies
aimed at better understanding the regulation of VZV transcript expression, and the
distinct roles of newly produced RNA 62 isoforms, pORF62, and tegument-derived
pORF62, are warranted.
In summary, this study describes the detailed analysis of the VZV transcriptome
architecture and kinetic classification of viral transcripts in the context of lytic VZV
infection. We provide these data as a comprehensive resource that will facilitate
functional studies of coding RNAs and their protein products, the role of noncoding
RNAs, and the regulation of VZV transcription and translation during lytic infection.
MATERIALS AND METHODS
Cells and viruses. Human retinal pigmented epithelium ARPE-19 cells (American Type Culture
Collection [ATCC] CRL-2302) were grown in a 1:1 (vol/vol) mixture of Dulbecco’s Modified Eagle’s
medium (DMEM) (Lonza) and Ham’s F-12 (Gibco) medium supplemented with 10% heat-inactivated fetal
bovine serum (FBS; Lonza) and 0.6 mg/ml L-sodium glutamate (Lonza) or in DMEM/F-12  GlutaMAX-I
(Thermo Fisher Scientific) supplemented with heat-inactivated 8% FBS (Sigma-Aldrich). Human neuro-
blastoma SH-SY5Y cells were grown in a 1:1 (vol/vol) mixture of Eagle’s Minimum Essential Medium
(EMEM) with Earle’s balanced salt solution (EBSS) (Lonza) and Ham’s F-12 (Gibco) medium supplemented
with 15% FBS (Lonza), L-sodium glutamate, penicillin-streptomycin, nonessential amino acids (MP
Biomedicals), and natrium-bicarbonate (Lonza). MRC-5 human embryonic lung fibroblasts and human
melanoma MeWo cells were cultured in DMEM (Lonza), supplemented with 10% FBS, L-sodium gluta-
mate, and penicillin-streptomycin. Human embryonic stem cell (hESC; H9)-derived neural stem cells (NSC)
(Thermo Fisher Scientific) were cultured, propagated, and differentiated into neurons as described
previously (63). Cell cultures were maintained at 37°C in a humidified CO2 incubator. VZV strain pOka
(parental Oka) was maintained in, and the cell-free virus was prepared from, ARPE-19 cells as described
previously for MRC-5 cells (37). VZV strain EMC-1 is a low-passage-number clinical isolate and was
cultured on ARPE-19 cells, and cell-free VZV was extracted as described previously (20, 64). Cell-free
EMC-1 was freshly harvested on the day of use and pretreated with DNase I, RNase T1, and RNase A (all
from Thermo Fisher Scientific) for 30 min at 37°C prior to infection.
RNA extraction and cDNA synthesis. ARPE-19 cells were infected with cell-associated VZV EMC-1
by cocultivation of uninfected and VZV EMC-1-infected ARPE-19 cells at an 8:1 cell ratio for 96 h.
Alternatively, ARPE-19, SH-SY5Y, MRC-5, and MeWo cells were infected with cell-free VZV EMC-1 for
indicated times. Cells were harvested in 1 ml TRIzol (Thermo Fisher Scientific), mixed with 200 l
chloroform, and centrifuged for 15 min at 12,000  g at 4°C. RNA was isolated from the aqueous phase
using the RNeasy minikit (Qiagen) according to manufacturer’s instructions, including on-column DNase
I treatment, as described previously (65). RNA concentration and integrity were analyzed using a
Nanodrop spectrophotometer (Thermo Fisher Scientific), and RNA was subjected to a second round of
DNase treatment using the Turbo DNA-free kit (Ambion) according to manufacturer’s instructions. For
cDNA synthesis, a maximum of 5 g RNA was reverse transcribed using Superscript IV reverse transcrip-
tase and oligo(dT) primers (Thermo Fisher Scientific) (RT). As control, the same reaction was performed
without reverse transcriptase (RT). Alternatively, RNA was isolated using the FavorPrep blood/cultured
cell total RNA minikit (Favorgen Biotech) in combination with the NucleoSpin RNA/DNA buffer set
(Macherey-Nagel). DNA was first eluted from the column in 100 l DNA elution buffer, subsequently the
column was treated with recombinant DNase I (20 units/100 l; Roche Diagnostics) for 30 min at 37°C,
and finally RNA was eluted in 50 l nuclease-free water. RNA was directly treated with Baseline-Zero
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DNase (2.5 units/50 l; Epicentre) for 30 min at 37°C. cDNA was synthesized with 12 l of RNA and
anchored oligo(dT)18 primer in a 20-l reaction mixture using the Transcriptor first-strand cDNA synthesis
kit at 55°C for 30 min for reverse transcriptase reaction (Roche Diagnostics).
PCR and sequence analysis. PCR was performed on RT and RT cDNA reaction mixtures using
AmpliTaq Gold DNA polymerase (Thermo Fisher Scientific) and primer pairs corresponding to each newly
identified VZV transcript (see Table S5 in the supplemental material). Primers were directed to the
predicted 5= and 3= ends of each transcript so that newly identified transcripts were completely amplified
from the 5= to the 3= end. For ORF9 variants and ORF48, additional reverse primers were used to confirm
splice junctions (Table S5). PCR amplification was performed as follows: initial denaturation at 95°C for
10 min, followed by 40 cycles of alternating denaturation (30 s, 95°C), primer annealing (30 s at the
appropriate temperature) (Table S5), and subsequently primer extension (1 min/1,000 bp, 72°C) (Ta-
ble S5). A final extension step of 10 min at 72°C was included. To amplify ORF13.5, each deoxynucleoside
triphosphate (dNTP), including equimolar amounts of dGTP and 7-deaza-GTP (New England Biolabs), was
used at a concentration of 200 M (66). PCR amplification of ORF13.5 was performed as follows: initial
touchup PCR from 58°C to 70°C using a transcript-specific forward primer and an anchored primer on the
poly(A) tail. Subsequently, seminested PCR was performed using the same forward primer and a reverse
primer within the transcript using standard PCR protocol. Amplicons were purified from gel using the
QIAquick gel extraction kit (Qiagen) and sequenced using the BigDye v3.1 cycle sequencing kit (Applied
Biosciences) with corresponding forward and reverse primers on the ABI Prism 3130 XL genetic analyzer.
Plasmid construction and generation of stable cell lines. The RNA 43-2 transcript sequence
(77775 to 78619 excluding the intron at 77869 to 78149; strain Dumas, NC_001348.1) was amplified using
cDNA from VZV EMC-1-infected ARPE-19 cells and primers NheI_ORF43-5_Fw and XhoI_ORF43.5_Rv
(Table S5). Amplicon was digested with NheI and XhoI and cloned into pcDNA3.1. Three independent
batches of ARPE-19 cells were transfected with either pcDNA3.1/empty or pcDNA3.1/RNA 43-2 using
polyethylenimine (PEI). After 2 days, cells were incubated with 1 mg/ml Geneticin and cultured for at
least 3 weeks to select for transfected cells. Subsequently, DNA was isolated using the QIAamp DNA
minikit according to manufacturer’s instructions and the presence of RNA 43-2 DNA was confirmed by
PCR. Next, RNA was isolated as described above, and expression of RNA 43-2 was confirmed by RT-PCR.
Flow cytometry. ARPE-19 cells stably transfected with pcDNA3.1/empty or pcDNA3.1/RNA 43-2 were
plated 1 day prior to infection in a 48-well plate. Cells were infected with cell-free VZV EMC-1 (multiplicity
of infection [MOI]  0.01), harvested at 48 hpi or 72 hpi, fixed and permeabilized with BD Cytofix/
Cytoperm, stained for VZV glycoprotein E (gE) (MAB8612; Millipore) in BD PermWash, and labeled with
secondary allophycocyanin (APC)-conjugated goat anti-mouse Ig antibody (BD Biosciences). The fre-
quency of VZV-infected (i.e., APC-positive) cells was measured on a BD FACSLyric flow cytometer and
analyzed using FlowJo software (BD Biosciences).
Plaque assay. Confluent monolayers of stable pcDNA3.1-empty or pcDNA3.1-RNA 43-2 cells grown
in a 12-well plate were infected with 2,000 PFU/well VZV EMC-1. At 72 h postinfection, plates were
washed and fixed with 4% paraformaldehyde (PFA) in PBS. Subsequently plates were permeabilized
using 0.1% Triton X-100 in PBS for 10 min, blocked with 5% normal goat serum in PBS-0.05% Tween 20
(PBS-T) for 30 min, and incubated with mouse anti-VZV gE antibody (MAB8612) diluted in PBS-T
containing 0.1% bovine serum albumin (BSA) for 1 h at room temperature. Cells were washed with PBS-T,
incubated for 1 h with polyclonal rabbit anti-mouse Ig antibody (Dako) in PBS-T  0.1% BSA, washed, and
stained with Alexa Fluor 488 (AF488)-conjugated goat anti-rabbit Ig (HL) antibody (Thermo Fisher) in
PBS-T. Plates were measured using the Immunospot S6 Ultimate UV image analyzer, and plaque size was
determined using Immunospot software (Cellular Technology Limited).
Kinetic class of VZV transcripts. ARPE-19 cells were synchronized in the cell cycle using a double
thymidine block approach (67). Briefly, ARPE-19 cells were seeded at semiconfluence in 12-well plates,
and on the next day medium was replaced with growth medium containing 2 mM thymidine (Sigma-
Aldrich). After 24 h, medium was replaced with normal growth medium for 8 h, after which medium was
changed back to thymidine-containing medium. Thirty minutes prior to infection, cells were released
from thymidine by replacing the medium with regular culture medium. Cells were infected with freshly
harvested cell-free VZV EMC-1 using spin-inoculation for 15 min at 1,000  g (MOI after spin-inocula-
tion  0.1 to 0.2). Cells were incubated for 45 min at 37°C, after which the inoculum was replaced with
fresh medium, medium with 10 g/ml actinomycin D (ActD; Sigma-Aldrich), medium with 50 g/ml
cycloheximide (CHX; C4859; Sigma-Aldrich), or medium with 400 g/ml phosphonoacetic acid (PAA;
Sigma-Aldrich). Infected cells were harvested in 500 l TRIzol at 12 hpi (ActD and CHX) or 24 hpi
(untreated and PAA) for RNA extraction. Alternatively, ARPE-19 cells, MRC-5 cells (1  105 cells/well on a
24-well plate), and hESC-derived neurons (1  105 cells/well on a 24-well plate as NSC and differentiated
for 18 days) were infected with cell-free VZV pOka (20 l of 4  104 PFU/ml) in the presence or absence
of phosphonoformic acid (200 g/ml) (Sigma-Aldrich) for 1 h, the inoculum was replaced with fresh
medium with phosphonoformic acid (200 g/ml), and cultures were maintained for 24 h.
Quantitative PCR analysis. Quantitative TaqMan real-time PCR (qPCR) was performed in duplicate
on RT and RT cDNA using 4 TaqMan Fast Advanced master mix (Applied Biosystems) on a 7500
TaqMan PCR system. Primer-probe sets directed to CDS regions of RNAs 61, 62, and 63 and VLT have
been described previously (9, 68), and those directed to ORF43 are described in Table S5 in the
supplemental material. Alternatively, cDNAs were subjected to qPCR using KOD SYBR qPCR mix (Toyobo)
in the StepOnePlus real-time PCR system (Thermo Fisher Scientific) (1 l of cDNA per 10-l reaction
mixture). All primer sets used for SYBR green chemistry (Table S5) were first confirmed for the
amplification rate (98 to 100%) using 10 to 106 copies (10-fold dilution) of pOka-BAC genome or VLT
plasmid (9) and the lack of nonspecific amplification using water. The qPCR program is as follows; 95°C
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for 2 min (1 cycle), 95°C for 10 s and 60°C for 15 s (40 cycles), and 60 to 95°C for a dissociation curve
analysis. Data are presented as relative VZV level to cellular beta-actin defined as 2  (threshold cycle [CT]
value VZV transcript  CT value beta-actin).
Northern blot analysis. Biotinylated probe directed to VZV ORF64 (nucleotides 111646 to 111936 in
reference strain Dumas, NC_001348.1) was generated using the MAXIscript kit (Ambion; Thermo Fisher
Scientific) according to the manufacturer’s instructions. Northern blot analysis was performed using the
NorthernMax-Gly kit (Ambion). In brief, 7.5 g total RNA extracted from mock- and VZV EMC-1-infected
ARPE-19 cells was separated by electrophoresis on a 1% agarose gel and transferred to a nylon
membrane (Brightstart-Plus; Ambion). Membranes were incubated for 15 min at 80°C to cross-link RNA,
prehybridized in ULTRAhyb buffer for 30 min at 68°C, and hybridized with biotinylated ORF64-specific
probe (0.1 nM diluted in ULTRAhyb buffer) overnight at 68°C. Probe binding was visualized using the AP
chemiluminescent blotting kit (KPL) and ChemiDoc MP imaging system (Bio-Rad).
Immunofluorescence staining. ARPE-19 cells were plated on glass coverslips in 24-well plates 1 day
prior to infection. Cells were inoculated with freshly harvested cell-free VZV EMC-1 in medium with or
without 400 g/ml PAA and incubated for 24 h. Infected cells were fixed with 4% PFA, permeabilized for
10 min with 0.1% Triton X-100 in PBS, blocked with 5% goat serum diluted in 0.2% gelatin-PBS solution,
and incubated on 30-l 0.2% gelatin-PBS droplets containing primary antibody overnight at 4°C. The
following primary antibodies were used: anti-pORF61 antibody (1:1,000, gift from P. Kinchington) and
monoclonal mouse anti-pORF62 antibody (1:200) (20). Cells were washed 3 times with 0.2% gelatin-PBS
and incubated for 1 h at room temperature with secondary antibodies diluted in 0.2% gelatin-PBS. The
following secondary antibodies were used: AF488-conjugated goat anti-rabbit Ig (HL) antibody (1:500;
Thermo Fisher) and AF594-conjugated goat anti-mouse Ig (HL) antibody (1:500; Thermo Fisher). Cells
were washed once with 0.2% gelatin-PBS, washed once with PBS, incubated with a 1:1,000 dilution of
Hoechst 33342 (Life Technologies, 20 mM) in PBS for 5 min, washed with PBS, and mounted using
Prolong Gold antifade mounting medium (Thermo Fisher). Stained cells were analyzed using a Zeiss LSM
700 confocal laser scanning microscope (Zeiss) with a magnification of 400 or 1,000. Photoshop CC
2019 software (Adobe) was used to adjust brightness and contrast.
Illumina RNA sequencing and analysis. Stranded RNA libraries were prepared from poly(A)-
selected RNA using the NEBNext Ultra II Directional RNA library prep kit for Illumina (New England
Biolabs) and sequenced using a NextSeq 550. Sequence reads were trimmed using TrimGalore (https://
www.bioinformatics.babraham.ac.uk/projects/trim_galore/) (–paired –length 30 – quality 30) and aligned
against the VZV reference genome (strain Dumas, NC_001348.1) using BBMAP (https://sourceforge.net/
projects/bbmap/) with postalignment processing performed using SAMtools (69) and BEDTools (70) to
generate BEDGRAPH and BED12 files. Candidate CPAS were identified using ContextMap2 (71)
(-aligner_name bowtie –polyA –strand-specific) with sequence reads aligned to VZV Dumas under
default parameters by BWA (72).
Cap Analysis Gene Expression (CAGE) sequencing (CAGE-Seq) and analysis. Two biological
replicates of total RNA were extracted from ARPE-19 cells infected with VZV pOka for 96 h and CAGE-Seq
libraries prepared by DNAform (Yokohama, Japan) and subsequently sequenced using an Illumina
NextSeq 550, as previously described (31). Resulting sequence reads were trimmed (–length 30 – q 30
– clip_R1 1) using TrimGalore prior to alignment against the VZV Dumas genome using BBMAP.
Postalignment processing was performed using SAMtools and BEDTools. TSS were identified using the
HOMER findPeaks module (-style tss -localSize 100 -size 15). Only TSS present in both biological replicates
were retained for analysis.
Nanopore direct RNA sequencing. For each biological sample, up to 1,000 ng of poly(A) RNA was
isolated from up to 50 g of total RNA using the Dynabeads mRNA purification kit (Invitrogen; catalog
no. 61006). Isolated poly(A) RNA was subsequently spiked with 0.3 l of a synthetic Enolase 2 (ENO2)
calibration RNA (Oxford Nanopore Technologies Ltd.), and dRNA-Seq libraries were prepared as de-
scribed previously (10). Sequencing was performed on a MinION MkIb using R9.4.1 (rev D) flow cells
(Oxford Nanopore Technologies Ltd.) for 18 to 44 h (one library per flowcell) and yielded between
720,000 and 1,290,000 reads per data set (Table S4). Raw fast5 data sets were then basecalled using
Guppy v3.2.2 (-f FLO-MIN106 -k SQK-RNA002) with only reads in the pass folder used for subsequent
analyses. Sequence reads were aligned against the VZV Dumas genome, using MiniMap2 (73) (-ax splice
-k14 -uf –secondaryno), with subsequent parsing through SAMtools and BEDTools. Here, sequence
reads were filtered to retain only primary alignments (alignment flag 0 [top strand] or 16 [bottom
strand]).
Splice junction correction in dRNA-Seq alignments. Illumina-assisted correction of splice junctions
in RNA-Seq data was performed using FLAIR v1.3 (30) in a stranded manner. Briefly, Illumina reads
aligning to the VZV Dumas genome were split according to orientation and mapping strand (-f83 & -f163
[forward] and -f99 & -f147 [reverse]) and used to produce strand-specific junction files that were filtered
to remove junctions supported by less than 50 Illumina reads. Direct RNA-Seq reads were similarly
aligned to the adenovirus type 5 (Ad5) genome and separated according to orientation (-F4095 [forward]
and -f16 [reverse]) prior to correction using the FLAIR correct module (default parameters). FLAIR-
corrected alignments were used for all subsequent downstream analyses.
TSS and CPAS identification in dRNA-Seq data. TSS and CPAS were identified by parsing SAM files
to BED12 files in a strand-specific manner using BEDTools and then truncating each aligned sequence
read to its 5= or 3= termini for TSS and CPAS identification, respectively. Peak regions containing TSS and
CPAS were identified using the HOMER findpeaks module (-o auto -style tss) using a –localSize of 100 and
500 and –size of 15 and 50 for TSS and CPAS, respectively. TSS peaks were compared against Illumina
annotated splice sites to identify and remove peak artifacts derived from local alignment errors around
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splice junctions. Thirty-eight putative TSS identified in the dRNA-Seq data set alone were flagged as
artifacts and removed. Each of these TSS mapped precisely to a splice acceptor within a spliced RNA, and
closer inspection of the reads showed these to result from local alignment processes (10).
Generating RNA abundance counts from dRNA-Seq data. Using the updated VZV strain Dumas
annotation presented here, we generated a transcriptome database by parsing our GFF3 file to a BED12
file using the gff3ToGenePred and genePredtoBED functions within UCSCutils (https://github.com/
itsvenu/UCSC-Utils-Download) and subsequently extracting a fasta sequence for each annotated RNA
using the getfasta function within BEDTools. dRNA-Seq reads were then aligned against the transcriptome
database using parameters optimized for transcriptome-level alignment (minimap2 -ax map-ont -p 0.99). RNA
abundance counts were generated by counting alignments against a given RNA only if the alignment 5= end
was located within the first 50 nt of the RNA and the alignment was not marked as supplementary. Transcript
per million (TPM) counts (Fig. 3) were generated by dividing the RNA abundance count for a given transcript
by the total number of sequence reads (one read  one RNA) present in the data set and subsequently
multiplying by 1 million. Note that where raw abundance counts were 	3, these counts were zeroed out to
minimize possible artifact introduced by low-level noise.
In silico prediction of coding potential. CPC 2.0 (36) was used to examine the coding potential of
all VZV RNAs defined in this study (Table S2). Note that RNAs were excluded from CPC 2.0 analysis and
defined as putatively noncoding if no proteins greater than 50 amino acids in length were encoded.
Data visualization. Figures associated with this study were generated using the R packages Gviz (74)
and GenomicRanges (75). Heatmaps were generated by uploading TPM counts (Table S3) to ClustVis (76)
with grouping of transcripts performed using the average correlation function.
Statistical analysis. Statistical analyses were performed where appropriate using GraphPad Prism 5
software with specific tests indicated in the figure legends.
Data availability. All sequencing data sets associated with this study are available via the European
Nucleotide Archive under the accession number PRJEB38829. Analyzed data sets generated as part of this
study, including a database of transcripts, BED12 alignment files, and GFF3 files describing our VZV
annotation, are freely available at https://github.com/DepledgeLab/vzv-2.0.
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Z, Boldogkői Z. 2018. Long-read sequencing uncovers a complex tran-
scriptome topology in varicella zoster virus. BMC Genomics 19:873.
https://doi.org/10.1186/s12864-018-5267-8.
19. Reichelt M, Brady J, Arvin AM. 2009. The replication cycle of varicella-
zoster virus: analysis of the kinetics of viral protein expression, genome
synthesis, and virion assembly at the single-cell level. J Virol 83:
3904 –3918. https://doi.org/10.1128/JVI.02137-08.
20. Lenac Rovis T, Bailer SM, Pothineni VR, Ouwendijk WJD, Simic H, Babic M,
Miklic K, Malic S, Verweij MC, Baiker A, Gonzalez O, von Brunn A, Zimmer
R, Fruh K, Verjans GMGM, Jonjic S, Haas J. 2013. Comprehensive analysis
of varicella-zoster virus proteins using a new monoclonal antibody
collection. J Virol 87:6943– 6954. https://doi.org/10.1128/JVI.00407-13.
21. Honess RW, Roizman B. 1974. Regulation of herpesvirus macromolecular
synthesis. I. Cascade regulation of the synthesis of three groups of viral
proteins. J Virol 14:8 –19. https://doi.org/10.1128/JVI.14.1.8-19.1974.
22. Kost RG, Kupinsky H, Straus SE. 1995. Varicella-zoster virus gene 63:
transcript mapping and regulatory activity. Virology 209:218 –224.
https://doi.org/10.1006/viro.1995.1246.
23. Moriuchi H, Moriuchi M, Straus SE, Cohen JI. 1993. Varicella-zoster virus
(VZV) open reading frame 61 protein transactivates VZV gene promoters
and enhances the infectivity of VZV DNA. J Virol 67:4290 – 4295. https://
doi.org/10.1128/JVI.67.7.4290-4295.1993.
24. Perera LP, Mosca JD, Ruyechan WT, Hayward GS, Straus SE, Hay J. 1993.
A major transactivator of varicella-zoster virus, the immediate-early
protein IE62, contains a potent N-terminal activation domain. J Virol
67:4474 – 4483. https://doi.org/10.1128/JVI.67.8.4474-4483.1993.
25. Moriuchi M, Moriuchi H, Straus SE, Cohen JI. 1994. Varicella-zoster virus
(VZV) virion-associated transactivator open reading frame 62 protein
enhances the infectivity of VZV DNA. Virology 200:297–300. https://doi
.org/10.1006/viro.1994.1190.
26. Defechereux P, Melen L, Baudoux L, Merville-Louis MP, Rentier B, Piette
J. 1993. Characterization of the regulatory functions of varicella-zoster
virus open reading frame 4 gene product. J Virol 67:4379 – 4385. https://
doi.org/10.1128/JVI.67.7.4379-4385.1993.
27. Ouwendijk WJD, Dekker L, Van den Ham H-J, Lenac Roviš T, Haefner ES,
Jonjic S, Haas J, Luider TM, Verjans GMGM. 2020. Analysis of virus and
host proteomes during productive HSV-1 and VZV infection in human
epithelial cells. Front Microbiol 11:1179. https://doi.org/10.3389/fmicb
.2020.01179.
28. Depledge DP, Mohr I, Wilson AC. 2018. Going the distance: optimizing
RNA-Seq strategies for transcriptomic analysis of complex viral genomes.
J Virol 93:e01342-18. https://doi.org/10.1128/JVI.01342-18.
29. Garalde DR, Snell EA, Jachimowicz D, Sipos B, Lloyd JH, Bruce M, Pantic
N, Admassu T, James P, Warland A, Jordan M, Ciccone J, Serra S, Keenan
J, Martin S, McNeill L, Wallace EJ, Jayasinghe L, Wright C, Blasco J, Young
S, Brocklebank D, Juul S, Clarke J, Heron AJ, Turner DJ. 2018. Highly
parallel direct RNA sequencing on an array of nanopores. Nat Methods
15:201–206. https://doi.org/10.1038/nmeth.4577.
30. Tang AD, Soulette CM, van Baren MJ, Hart K, Hrabeta-Robinson E, Wu CJ,
Brooks AN. 2020. Full-length transcript characterization of SF3B1 mutation
in chronic lymphocytic leukemia reveals downregulation of retained in-
trons. Nat Commun 11:1438. https://doi.org/10.1038/s41467-020-15171-6.
31. Murata M, Nishiyori-Sueki H, Kojima-Ishiyama M, Carninci P, Hayashizaki
Y, Itoh M. 2014. Detecting expressed genes using CAGE. Methods Mol
Biol 1164:67– 85. https://doi.org/10.1007/978-1-4939-0805-9_7.
32. Thorvaldsdóttir H, Robinson JT, Mesirov JP. 2013. Integrative Genomics
Viewer (IGV): high-performance genomics data visualization and explo-
ration. Brief Bioinform 14:178 –192. https://doi.org/10.1093/bib/bbs017.
33. Kemble GW, Annunziato P, Lungu O, Winter RE, Cha T-A, Silverstein SJ,
Spaete RR. 2000. Open reading frame S/L of varicella-zoster virus en-
codes a cytoplasmic protein expressed in infected cells. J Virol 74:
11311–11321. https://doi.org/10.1128/jvi.74.23.11311-11321.2000.
34. Sadaoka T, Yanagi T, Yamanishi K, Mori Y. 2010. Characterization of the
Varicella-zoster virus ORF50 gene, which encodes glycoprotein M. J Virol
84:3488 –3502. https://doi.org/10.1128/JVI.01838-09.
35. Jensen NJ, Depledge DP, Ng TFF, Leung J, Quinlivan M, Radford KW,
Folster J, Tseng H-F, LaRussa P, Jacobsen SJ, Breuer J, Schmid DS. 2020.
Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus.
Virology 546:38 –50. https://doi.org/10.1016/j.virol.2020.03.008.
36. Kang YJ, Yang DC, Kong L, Hou M, Meng YQ, Wei L, Gao G. 2017. CPC2:
a fast and accurate coding potential calculator based on sequence
intrinsic features. Nucleic Acids Res 45:W12–W16. https://doi.org/10
.1093/nar/gkx428.
37. Sadaoka T, Yoshii H, Imazawa T, Yamanishi K, Mori Y. 2007. Deletion in
open reading frame 49 of varicella-zoster virus reduces virus growth in
human malignant melanoma cells but not in human embryonic fibro-
blasts. J Virol 81:12654 –12665. https://doi.org/10.1128/JVI.01183-07.
38. Cox E, Reddy S, Iofin I, Cohen JI. 1998. Varicella-zoster virus ORF57, unlike
its pseudorabies virus UL3.5 homolog, is dispensable for viral replication
in cell culture. Virology 250:205–209. https://doi.org/10.1006/viro.1998
.9349.
39. Cohrs RJ, Hurley MP, Gilden DH. 2003. Array analysis of viral gene
transcription during lytic infection of cells in tissue culture with varicella-
zoster virus. J Virol 77:11718 –11732. https://doi.org/10.1128/jvi.77.21
.11718-11732.2003.
40. Norberg P, Depledge DP, Kundu S, Atkinson C, Brown J, Haque T,
Hussaini Y, MacMahon E, Molyneaux P, Papaevangelou V, Sengupta N,
Koay ESC, Tang JW, Underhill GS, Grahn A, Studahl M, Breuer J, Berg-
ström T. 2015. Recombination of globally circulating varicella-zoster
virus. J Virol 89:7133–7146. https://doi.org/10.1128/JVI.00437-15.
41. Sadaoka T, Schwartz CL, Rajbhandari L, Venkatesan A, Cohen JI. 2017.
Human embryonic stem cell-derived neurons are highly permissive for
Braspenning et al. ®
September/October 2020 Volume 11 Issue 5 e01568-20 mbio.asm.org 18
 on N
ovem
ber 13, 2020 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
varicella-zoster virus lytic infection. J Virol 92:e01108-17. https://doi.org/
10.1128/JVI.01108-17.
42. Sadaoka T, Depledge DP, Rajbhandari L, Venkatesan A, Breuer J, Cohen
JI. 2016. In vitro system using human neurons demonstrates that
varicella-zoster vaccine virus is impaired for reactivation, but not latency.
Proc Natl Acad Sci U S A 113:E2403–E2412. https://doi.org/10.1073/pnas
.1522575113.
43. Baird NL, Bowlin JL, Cohrs RJ, Gilden D, Jones KL. 2014. Comparison of
varicella-zoster virus RNA sequences in human neurons and fibroblasts.
J Virol 88:5877–5880. https://doi.org/10.1128/JVI.00476-14.
44. Zhang Z, Selariu A, Warden C, Huang G, Huang Y, Zaccheus O, Cheng T,
Xia N, Zhu H. 2010. Genome-wide mutagenesis reveals that ORF7 is a
novel VZV skin-tropic factor. PLoS Pathog 6:e1000971. https://doi.org/
10.1371/journal.ppat.1000971.
45. Toropova K, Huffman JB, Homa FL, Conway JF. 2011. The herpes simplex
virus 1 UL17 protein is the second constituent of the capsid vertex-
specific component required for DNA packaging and retention. J Virol
85:7513–7522. https://doi.org/10.1128/JVI.00837-11.
46. Yang M, Hay J, Ruyechan WT. 2004. The DNA element controlling
expression of the varicella-zoster virus open reading frame 28 and 29
genes consists of two divergent unidirectional promoters which have a
common USF site. J Virol 78:10939 –10952. https://doi.org/10.1128/JVI
.78.20.10939-10952.2004.
47. Storlie J, Jackson W, Hutchinson J, Grose C. 2006. Delayed biosynthesis
of varicella-zoster virus glycoprotein C: upregulation by hexamethylene
bisacetamide and retinoic acid treatment of infected cells. J Virol 80:
9544 –9556. https://doi.org/10.1128/JVI.00668-06.
48. Koshizuka T, Ota M, Yamanishi K, Mori Y. 2010. Characterization of
varicella-zoster virus-encoded ORF0 gene– comparison of parental and
vaccine strains. Virology 405:280 –288. https://doi.org/10.1016/j.virol
.2010.06.016.
49. Felser JM, Kinchington PR, Inchauspe G, Straus SE, Ostrove JM. 1988. Cell
lines containing varicella-zoster virus open reading frame 62 and ex-
pressing the “IE” 175 protein complement ICP4 mutants of herpes
simplex virus type 1. J Virol 62:2076 –2082. https://doi.org/10.1128/JVI
.62.6.2076-2082.1988.
50. Leppek K, Das R, Barna M. 2018. Functional 5= UTR mRNA structures in
eukaryotic translation regulation and how to find them. Nat Rev Mol Cell
Biol 19:158 –174. https://doi.org/10.1038/nrm.2017.103.
51. Tyler SD, Peters GA, Grose C, Severini A, Gray MJ, Upton C, Tipples GA.
2007. Genomic cartography of varicella-zoster virus: a complete
genome-based analysis of strain variability with implications for atten-
uation and phenotypic differences. Virology 359:447– 458. https://doi
.org/10.1016/j.virol.2006.09.037.
52. Jones M, Dry IR, Frampton D, Singh M, Kanda RK, Yee MB, Kellam P,
Hollinshead M, Kinchington PR, O’Toole EA, Breuer J. 2014. RNA-seq
analysis of host and viral gene expression highlights interaction be-
tween varicella zoster virus and keratinocyte differentiation. PLoS Pat-
hog 10:e1003896. https://doi.org/10.1371/journal.ppat.1003896.
53. Hancock MH, Skalsky RL. 2018. Roles of non-coding RNAs during her-
pesvirus infection. Curr Top Microbiol Immunol 419:243–280. https://doi
.org/10.1007/82_2017_31.
54. Saxena A, Carninci P. 2011. Long non-coding RNA modifies chromatin:
epigenetic silencing by long non-coding RNAs. Bioessays 33:830 – 839.
https://doi.org/10.1002/bies.201100084.
55. Pelechano V, Steinmetz LM. 2013. Gene regulation by antisense tran-
scription. Nat Rev Genet 14:880 – 893. https://doi.org/10.1038/nrg3594.
56. Zhang C, Hastings ML, Krainer AR, Zhang MQ. 2007. Dual-specificity
splice sites function alternatively as 5= and 3= splice sites. Proc Natl Acad
Sci U S A 104:15028 –15033. https://doi.org/10.1073/pnas.0703773104.
57. Michael EJ, Kuck KM, Kinchington PR. 1998. Anatomy of the varicella
zoster virus openreading frame 4 promoter. J Infect Dis 178:S27–S33.
https://doi.org/10.1086/514273.
58. Wang L, Sommer M, Rajamani J, Arvin AM. 2009. Regulation of the
ORF61 promoter and ORF61 functions in varicella-zoster virus replication
and pathogenesis. J Virol 83:7560 –7572. https://doi.org/10.1128/JVI
.00118-09.
59. Kinchington PR, Hougland JK, Arvin AM, Ruyechan WT, Hay J. 1992. The
varicella-zoster virus immediate-early protein IE62 is a major component
of virus particles. J Virol 66:359 –366. https://doi.org/10.1128/JVI.66.1.359
-366.1992.
60. Perera LP, Mosca JD, Sadeghi-Zadeh M, Ruyechan WT, Hay J. 1992. The
varicella-zoster virus immediate early protein, IE62, can positively regu-
late its cognate promoter. Virology 191:346 –354. https://doi.org/10
.1016/0042-6822(92)90197-w.
61. Yang M, Peng H, Hay J, Ruyechan WT. 2006. Promoter activation by the
varicella-zoster virus major transactivator IE62 and the cellular transcrip-
tion factor USF. J Virol 80:7339 –7353. https://doi.org/10.1128/JVI.00309
-06.
62. Ruyechan WT, Peng H, Yang M, Hay J. 2003. Cellular factors and IE62
activation of VZV promoters. J Med Virol 70(Suppl 1):S90 –S94. https://
doi.org/10.1002/jmv.10328.
63. Sadaoka T, Rajbhandari L, Shukla P, Jagdish B, Lee H, Lee G, Venkatesan
A. 2020. Human stem cell derived sensory neurons are positioned to
support varicella zoster virus latency. bioRxiv. https://doi.org/10.1101/
2020.01.24.919290.
64. Ouwendijk WJD, Geluk A, Smits SL, Getu S, Osterhaus ADME, Verjans
GMGM. 2014. Functional characterization of ocular-derived human al-
phaherpesvirus cross-reactive CD4 T cells. J Immunol 192:3730 –3739.
https://doi.org/10.4049/jimmunol.1302307.
65. Ouwendijk WJD, Mahalingam R, de Swart RL, Haagmans BL, van Amer-
ongen G, Getu S, Gilden D, Osterhaus ADME, Verjans GMGM. 2013. T-cell
tropism of simian varicella virus during primary infection. PLoS Pathog
9:e1003368. https://doi.org/10.1371/journal.ppat.1003368.
66. Maertzdorf J, Remeijer L, Van Der Lelij A, Buitenwerf J, Niesters HGM,
Osterhaus ADME, Verjans GMGM. 1999. Amplification of reiterated se-
quences of herpes simplex virus type 1 (HSV-1) genome to discriminate
between clinical HSV-1 isolates. J Clin Microbiol 37:3518 –3523. https://
doi.org/10.1128/JCM.37.11.3518-3523.1999.
67. Ma HT, Poon RYC. 2017. Synchronization of HeLa cells. Methods Mol Biol
1524:189 –201. https://doi.org/10.1007/978-1-4939-6603-5_12.
68. Ouwendijk WJD, Choe A, Nagel MA, Gilden D, Osterhaus ADME, Cohrs RJ,
Verjans GMGM. 2012. Restricted varicella-zoster virus transcription in
human trigeminal ganglia obtained soon after death. J Virol 86:
10203–10206. https://doi.org/10.1128/JVI.01331-12.
69. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G,
Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup.
2009. The Sequence Alignment/Map format and SAMtools. Bioinformat-
ics 25:2078 –2079. https://doi.org/10.1093/bioinformatics/btp352.
70. Quinlan AR, Hall IM. 2010. BEDTools: a flexible suite of utilities for
comparing genomic features. Bioinformatics 26:841– 842. https://doi
.org/10.1093/bioinformatics/btq033.
71. Bonfert T, Kirner E, Csaba G, Zimmer R, Friedel CC. 2015. ContextMap 2:
fast and accurate context-based RNA-seq mapping. BMC Bioinformatics
16:122. https://doi.org/10.1186/s12859-015-0557-5.
72. Li H, Durbin R. 2009. Fast and accurate short read alignment with
Burrows-Wheeler transform. Bioinformatics 25:1754 –1760. https://doi
.org/10.1093/bioinformatics/btp324.
73. Li H. 2018. Minimap2: pairwise alignment for nucleotide sequences. Bioin-
formatics 34:3094–3100. https://doi.org/10.1093/bioinformatics/bty191.
74. Hahne F, Ivanek R. 2016. Visualizing genomic data using Gviz and
bioconductor. Methods Mol Biol 1418:335–351. https://doi.org/10.1007/
978-1-4939-3578-9_16.
75. Lawrence M, Huber W, Pagès H, Aboyoun P, Carlson M, Gentleman R,
Morgan MT, Carey VJ. 2013. Software for computing and annotating
genomic ranges. PLoS Comput Biol 9:e1003118. https://doi.org/10.1371/
journal.pcbi.1003118.
76. Metsalu T, Vilo J. 2015. ClustVis: a web tool for visualizing clustering of
multivariate data using principal component analysis and heatmap.
Nucleic Acids Res 43:W566 –W570. https://doi.org/10.1093/nar/gkv468.
77. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre
C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining
transcription factors prime cis-regulatory elements required for macro-
phage and B cell identities. Mol Cell 38:576 –589. https://doi.org/10
.1016/j.molcel.2010.05.004.
78. Ouwendijk WJD, Depledge DP, Rajbhandari L, Lenac Rovis T, Jonjic S,
Breuer J, Venkatesan A, Verjans GMGM, Sadaoka T. 2020. Expression of
varicella-zoster virus VLT-ORF63 fusion transcript induces broad viral
gene expression during reactivation from neuronal latency. bioRxiv.
https://doi.org/10.1101/2020.09.11.294280.
Decoding the VZV Transcriptome ®
September/October 2020 Volume 11 Issue 5 e01568-20 mbio.asm.org 19
 on N
ovem
ber 13, 2020 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
